Fundraising FoxSangel Capital
Venture capitalShenzhen · Seed–Late Stage · 2 people tracked
Find your way into Sangel Capital
Sign up to see every warm intro you have to Sangel Capital
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Sangel Capital team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
Sangel Venture concentrates on the life science and technology sector, positioning itself as one of China's earliest professional biomedical venture investors. Drawing on deep industry expertise and project resources, it identifies innovative growth-stage enterprises with strong capital value and commercial potential, aiming to build benchmark companies across subdivided segments of the biomedical industry. The firm assembles investment and advisory teams of industry experts, scientists, and investors in life technology to manage a series of both RMB- and USD-denominated funds.
Source: firm website, verified Oct 3, 2026.
Team · 2 people
from the firm's websiteWhat they invest in
from 7 of 14 portfolio companiesBiotech ×7Healthtech ×4Medical Devices ×4Digital Health ×2Advanced Manufacturing ×1AI & Machine Learning ×1B2B Marketplaces ×1Deep Tech ×1
HQs:United States×3China×2
Investments · 14 tracked
founders shown can be your intro path
Beyond Spring Pharmaceuticals develops Plinabulin, a brain-penetrant immune modulator that activates dendritic cells through a differentiated tubulin-binding mechanism, intended to enhance antigen presentation and T cell activation for select tumor types.
BiotechHealthtechMedical Devices
Co-investorsDecheng CapitalEFung Capital
BiotechMenlo Park, US
Cuiping Gu(Director)David Parkinson(Director)inZhenping Zhu(Director)Karen Liu(Director)Bing C. Wang(Executive Officer, Director)
Co-investorsDanhua CapitalShangBay Capital LLCWuXi Healthcare Ventures
Vizgen develops high-throughput spatial profiling technologies, including MERFISH-based spatial genomics and spatial proteomics tools for life science research and precision oncology.
AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesCambridge, US
George Emanuel(Scientific Cofounder, VP & Portfolio Owner, Instruments)inJiang He(Scientific Cofounder, VP & Portfolio Owner, Reagents & Scientific Affairs)inXiaowei Zhuang(Founder; Professor, Harvard University)inFenel Eloi(Director)Rob Carson(Chief Executive Officer)inSimona Levi(Chief Legal Officer)in
Co-investorsARCH Venture PartnersNorthpond Ventures6 Dimensions CapitalAlly Bridge GroupApplied VenturesKilonova Capital+3 more
KBP Biosciences is a biotechnology research and development organization that discovers and develops innovative therapeutic drugs for unmet medical needs using an integrated discovery and development platform.
Biotech
Co-investorsEFung Capital
Shanghai Jizhi Biochemical is a reagent company specializing in the research and development of biochemical reagents and life science products.
Advanced ManufacturingB2B MarketplacesBiotechE-commerceHangzhou, CN
A research-driven specialty pharmaceutical company that develops and commercializes innovative medicines through the 505(b)(2) regulatory pathway, focusing on central nervous system disorders, metabolic diseases, and orphan indications.
BiotechDigital HealthHealthtechMedical DevicesNew Jersey, US
Shoufeng Li(Chief Executive Officer)
Pharma technology company founded in 2010 focused on precision oncology medicine.
Co-investorsCo-Win VenturesEFung Capital
Uni-medica develops automated fluorescence staining and analysis systems, nucleic acid detection kits, and high-throughput sequencing products for molecular diagnostic applications including cervical cancer screening, pathogen detection, and genetic disease identification.
BiotechDigital HealthHealthtechMedical DevicesShenzhen, CN
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
LamtherapeuticsVersaeutics喜鹊医药宝来通艾欣达伟苏州沪云
Frequently asked questions
- How many investments has Sangel Capital made?
- Sangel Capital has 14 tracked investments, 1 of which have exited.
- What stage does Sangel Capital invest at?
- Sangel Capital invests at the Seed, Series A, Growth, Late Stage stages.
- What sectors does Sangel Capital focus on?
- Sangel Capital focuses on Biotech, Digital Health, Healthtech, Longevity, Medical Devices.
- Where is Sangel Capital located?
- Sangel Capital is headquartered in Shenzhen, CN.
- Who does Sangel Capital co-invest with?
- Sangel Capital most often shares deals with EFung Capital, Co-Win Ventures, Decheng Capital, among 3 tracked co-investors.
Similar investors
GV (Google Ventures) is a venture capital firm that has invested in AI and machine learning since its early days, backing more than 100 AI companies across infrastructure, life sciences, and applications.
5AM Ventures is a life science venture capital firm founded in 2002 that funds and builds next-generation life sciences companies, focusing on biopharmaceuticals, drug delivery technologies, and life science instruments.
Novo Holdings is the holding and investment company that manages the assets of the Novo Nordisk Foundation, serving as controlling shareholder of Novo Nordisk and Novonesis. It invests in life science companies across all stages and manages a diversified portfolio of equities, bonds, real estate, infrastructure and private equity.
OrbiMed is a healthcare-focused investment firm providing tailored financing solutions and global resources to build world-class healthcare companies across biopharmaceuticals, medical devices, digital health, diagnostics, and healthcare services.
Foresite Capital is a healthcare-focused investment firm backing companies at the intersection of technology and biotechnology to personalize healthcare and accelerate medical innovation.